Chemotherapy-Induced Cardiomyopathy: Clinical Scenarios and ChallengesOctober 15th 2015
We will discuss the deleterious cardiovascular effects of anthracyclines and HER2-targeted agents in a case-based format, as well as specific approaches to prevention and treatment of associated cardiotoxicity.
Bevacizumab and Glioblastoma: The Ecstasy and the AgonyOctober 15th 2015
The absence of any effective combinatorial therapy in patients progressing on bevacizumab and evidence supporting both continuation and discontinuation of bevacizumab in this setting remain important areas for additional clinical trial evaluation in order to better guide our therapeutic decision making in the clinic.
Chemotherapy-Free Treatment of Follicular Lymphoma: We Have the Ingredients, Now for Some RecipesOctober 15th 2015
The treatment of patients with follicular lymphoma is undergoing a substantial shift due to rapid development of highly effective agents targeting lymphoma-specific biologic processes and the tumor microenvironment.
Salivary Gland Cancers: The Challenges of Progress in Rare TumorsOctober 15th 2015
The diversity and complexity, combined with the rarity of salivary gland malignancies, lead to definite and distinct challenges in their study, and consequently in advancing treatment options for affected patients.